|
- RP1-261G23.1,
- MGC70609,
- VEGF,
- VEGF-A,
- VPF
- vascular permeability factor
|
|
- Growth factor active in angiogenesis, vasculogenesis and endothelial cell growth.
Induces endothelial cell proliferation, promotes cell migration, inhibits apoptosis, and
induces permeabilization of blood vessels. Binds to the VEGFR1/Flt-1 and VEGFR2/Kdr
receptors, heparan sulfate and heparin. Neuropilin-1 binds isoforms VEGF-165 and VEGF-145.
|
|
- Location: 6p12
- Size: 16272 bp
- exons:
- Transcript variant1: 8
- Transcript variant2: 8
- Transcript variant3: 8
- Transcript variant4: 7
- Transcript variant5: 7
- Transcript variant6: 6
- Transcript variant7: 7
- DNA sequence (Human): NC_000006.10
|
- Mutations and SNPs (According
to HGMD and SNP)
|
|
|
mRNA
sequence (Human):
Transcript
variant1: NM_001025366.1
Transcript
variant2: NM_003376.4
Transcript
variant3: NM_001025367.1
Transcript
variant4: NM_001025368.1
Transcript
variant5: NM_001025369.1
Transcript
variant6: NM_001025370.1
Transcript
variant7: NM_001033756.1
Size:
Transcript
variant1: 3665 bp
Transcript
variant2: 3614 bp
Transcript
variant3: 3596 bp
Transcript
variant4: 3542 bp
Transcript
variant5: 3507 bp
Transcript
variant6: 3410 bp
Transcript
variant7: 3476 bp
cDNA
libraries:
|
|
- Size: 232 amino acids: 27042 Da
- Catalytic activity:
Subcellular
location: Secreted. Note=VEGF121 is acidic and freely secreted. VEGF165 is more
basic, has heparin-binding properties and, although a signicant proportion remains
cell-associated, most is freely secreted. VEGF189 is very basic, it is cell-associated
after secretion and is bound avidly by heparin and the extracellular matrix, although it
may be released as a soluble form by heparin, heparinase or plasmin.
Protein
domains
|
|
|
|
|
|
|